Rifampicin-monoresistant Mycobacterium tuberculosis disease among children in Cape Town, South Africa

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 1, 2012, Pages 76-81

  Dramowski, A ^a   Morsheimer, M M ^b   Jordaan, A M ^c   Victor, T C ^c   Donald, P R ^a,c   Schaaf, H S ^a,c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Drug resistant TB; HIV; Rifampicin; Rifampicin monoresistance; TB

Indexed keywords

ANTIRETROVIRUS AGENT; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULIN;

ACID FAST BACTERIUM; ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CHILD; CHILDHOOD MORTALITY; CLINICAL ARTICLE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHA GENE; KATG GENE; LUNG TUBERCULOSIS; MALE; MEDICAL RECORD REVIEW; MIXED INFECTION; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RPOB GENE; SCHOOL CHILD; SOUTH AFRICA; SPUTUM SMEAR; THERAPY DELAY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS CONTROL; TUBERCULOUS MENINGITIS;

ADOLESCENT; AGE FACTORS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBIOTICS, ANTITUBERCULAR; CHILD; CHILD, PRESCHOOL; COINFECTION; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV INFECTIONS; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RIFAMPIN; SOUTH AFRICA; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84555186660     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0360     Document Type: Article

References (29)

1. Nelson L J, Wells C D. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004; 8: 636-647. (Pubitemid 38625076)
2. Mahomed H, Kibel M, Hawkridge T, et al. The impact of a change in bacille Calmette-Guerin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa. Pediatr Infect Dis J 2006; 25: 1167-1172. (Pubitemid 44900682)
3. World Health Organization. Global report: UNAIDS report on the global AIDS epidemic UNAIDS/10.11E/JC1958E. Geneva, Switzerland: WHO, 2010. http://www.unaids.org/documents/20101123-GlobalReport-em.pdf Accessed October 2011.
4. Shisana O, Rehle T, Simbayi L C, et al. and the SABSSM III Implementation Team. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2008: a turning tide among teenagers? Pretoria, South Africa: Human Sciences Research Council, 2009. http://www.mrc.ac.za/ pressreleases/2009/sanat.pdf Accessed October 2011.
5. Hesseling A C, Cotton M F, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009; 48: 108-114.
6. Schaaf H S, Marais B J, Hesseling A C, Gie R P, Beyers N, Donald P R. Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatr 2006; 95: 523-528. (Pubitemid 43791572)
7. Schaaf H S, Marais B J, Hesseling A C, Brittle W, Donald P R. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa - an upward trend. Am J Public Health 2009; 99: 1486-1490.
8. Schaaf H S, Marais B J, Whitelaw A, et al. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis 2007; 7: 140.
9. Schaaf H S, Gie R P, Beyers N, Sirgel F A, de Klerk P J, Donald P R. Primary drug-resistant tuberculosis in children. Int J Tuberc Lung Dis 2000; 4: 1149-1155. (Pubitemid 32046293)
10. Sanders M, Van Deun A, Ntakirutimana D, et al. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey. Int J Tuberc Lung Dis 2006; 10: 178-183. (Pubitemid 43275542)
11. Talbot E A, Kenyon T A, Mwasekaga M J, Moeti T L, Mallon V, Binkin N J. Control of anti-tuberculosis drug resistance in Botswana. Int J Tuberc Lung Dis 2003; 7: 72-77. (Pubitemid 36427034)
12. Pinto W P, Hadad D J, Silva Telles M A, Ueki S Y, Palaci M, Basile M A. Tuberculosis and drug resistance among patients seen at an AIDS Reference Center in Sao Paulo, Brazil. Int J Infect Dis 2001; 5: 93-100.
13. Bradford W Z, Martin J N, Reingold A L, Schecter G F, Hopewell P C, Small P M. The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet 1996; 348: 928-931. (Pubitemid 26333851)
14. Bohmer P D, Macnab M F, Coetzee G J. Primary drug resistance in Mycobacterium tuberculosis in the greater Cape Town area. S Afr Med J 1992; 81: 382-383.
15. Mukinda F K, Theron D, Van der Spuy G, et al. Rifampicin mono-resistant tuberculosis in Western Cape, South Africa: a case-control study. Int J Tuberc Lung Dis 2012; 16 (in press).
16. Bifani P, Mathema B, Kurepina N, et al. The evolution of drug resistance in Mycobacterium tuberculosis: from a monorifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population. J Infect Dis 2008; 198: 90-94. (Pubitemid 351920294)
17. Shimao T. Drug resistance in tuberculosis control. Tubercle 1987; 68: 5-18.
18. Sandman L, Schluger N W, Davidow A L, Bonk S. Risk factors for rifampin-monoresistant tuberculosis: a case-control study. Am J Respir Crit Care Med 1999; 159: 468-472. (Pubitemid 29084867)
19. Ridzon R, Whitney C G, McKenna M T, et al. Risk factors for rifampin mono-resistant tuberculosis. Am J Respir Crit Care Med 1998; 157: 1881-1884.
20. Vernon A, Burman W, Benator D, Khan A, Bozeman L. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Lancet 1999; 353: 1843-1847. (Pubitemid 29251017)
21. Centers for Disease Control and Prevention. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens. MMWR 2002; 51: 214-215.
22. Sonnenberg P, Murray J, Glynn J R, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and re-infection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358: 1687-1693. (Pubitemid 33124328)
23. Kreiswirth B N. Selective malabsorption and the origin of mono-rifampin-resistant Mycobacterium tuberculosis [Correspondence]. Am J Respir Crit Care Med 1996; 154: 1213. (Pubitemid 26346894)
24. Mariappan T T, Singh S. Evidence of efflux-mediated and saturable absorption of rifampicin in rat intestine using the ligated loop and everted gut sac techniques. Molecular Pharmaceutics 2004; 1: 363-367.
25. Munsiff S S, Joseph S, Ebrahimzadeh A, Frieden T R. Rifampin- monoresistant tuberculosis in New York City, 1993-1994. Clin Infect Dis 1997; 25: 1465-1467. (Pubitemid 28022689)
26. March F, Garriga X, Rodriguez P, et al. Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis. Clin Infect Dis 1997; 25: 1044-1047. (Pubitemid 27513183)
27. Nettles R E, Mazo D, Alwood K, et al. Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use. Clin Infect Dis 2004; 38: 731-736. (Pubitemid 38333871)
28. Espinal M A, Kim S J, Suarez P G, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000; 283: 2537-2545. (Pubitemid 30324196)
29. Drobac P C, Mukherjee J S, Joseph J K, et al. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics 2006; 117: 2022-2029. (Pubitemid 46071247)